Biotheranostics Competitors and Similar CompaniesClear all
Personalis's competitors and similar companies include Biocept.
 Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. | ||
Founding Date | Founding Date 2011 | Founding Date 1993 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Fremont, US HQ West Wickham, GB | Locations San Diego, US HQ |
Employees | Employees 22344% decrease | Employees 878% decrease |
Valuation ($) | Valuation ($) 340.9 m | Valuation ($) N/A |
Financial | ||
Revenue (est.) | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) $25.9m (FY, 2022) |
Cost of goods | Cost of goods $53.9m (FY, 2025) | Cost of goods $28.4m (FY, 2022) |
Gross profit | Gross profit $15.8m (FY, 2025) | Gross profit ($2.5m) (FY, 2022) |
Net income | Net income ($81.3m) (FY, 2025) | Net income ($32.1m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 75m | Total funding raised $ 15.9m |
For sources of this data, please see the company profile
View Company Profiles
Biocept
HQ
San Diego, US
Employees
87↓ 8% decrease
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
View company